As for other EIF3 subunits, several studies have investigated their roles in tumors, including bladder cancer and pancreatic cancer [51,52], OV [39], cervical cancer [53], LUAD (lung adenocarcinoma) [54], and HCC [55]; few studies mention their role in breast cancer. Here, EIF3A is linked to hepatocellular carcinoma.